A detailed history of Nisa Investment Advisors, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 75 shares of VRCA stock, worth $596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 34 120.59%
Holding current value
$596
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$7.95 - $7.95 $325 - $325
41 Added 120.59%
75 $0
Q2 2024

Jul 19, 2024

BUY
$5.89 - $9.56 $200 - $325
34 New
34 $0
Q1 2022

Apr 29, 2022

SELL
$7.59 - $9.49 $23,529 - $29,419
-3,100 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$9.1 - $13.36 $12,740 - $18,704
-1,400 Reduced 31.11%
3,100 $25,000
Q2 2021

Aug 06, 2021

BUY
$9.77 - $15.33 $43,965 - $68,985
4,500 New
4,500 $51,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.